Fig. 3From: Repurposing of approved cardiovascular drugsLocal RAS, ACE inhibitors and ARBS in tumor cells. In tumor cells, angiotensin II promotes VEGF production via AT1 receptor, resulting in increased angiogenesis. ACE inhibitors and ARBs attenuate local RAS and reduce VEGF-dependent angiogenic signals in cancerBack to article page